Hammer Sm

670 total citations
27 papers, 542 citations indexed

About

Hammer Sm is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Hammer Sm has authored 27 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 15 papers in Virology and 6 papers in Epidemiology. Recurrent topics in Hammer Sm's work include HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (14 papers) and HIV/AIDS Research and Interventions (10 papers). Hammer Sm is often cited by papers focused on HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (14 papers) and HIV/AIDS Research and Interventions (10 papers). Hammer Sm collaborates with scholars based in United States, Thailand and France. Hammer Sm's co-authors include P Pinkston, Gavin X. McLeod, Ketil Jarl Holen, Lars Engebretsen, P. Yéni, Louise Pedneault, Håkon Lund-Hanssen, Jean‐Marie Gillis, Richard C. Reichman and R. Chung and has published in prestigious journals such as Blood, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

Hammer Sm

26 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hammer Sm United States 15 318 277 112 74 64 27 542
Michael K. Klebert United States 8 449 1.4× 166 0.6× 57 0.5× 9 0.1× 100 1.6× 10 569
Catherine Dhiver France 8 307 1.0× 252 0.9× 116 1.0× 48 0.6× 46 0.7× 10 570
Barbara Rossetti Italy 16 498 1.6× 230 0.8× 238 2.1× 104 1.4× 53 0.8× 63 769
Antonia L. Moore United Kingdom 11 537 1.7× 362 1.3× 166 1.5× 33 0.4× 27 0.4× 17 742
Li Ts China 7 305 1.0× 350 1.3× 221 2.0× 37 0.5× 118 1.8× 19 598
Michael Stek United States 12 318 1.0× 178 0.6× 140 1.3× 49 0.7× 2 0.0× 17 557
Kailapuri G. Murugavel India 16 232 0.7× 149 0.5× 340 3.0× 57 0.8× 75 1.2× 47 599
Barbara Baird United States 10 228 0.7× 166 0.6× 565 5.0× 22 0.3× 59 0.9× 11 736
Christian Aquilina France 8 246 0.8× 241 0.9× 63 0.6× 29 0.4× 21 0.3× 10 399
Mervyn Tyrer United Kingdom 15 668 2.1× 496 1.8× 227 2.0× 72 1.0× 32 0.5× 27 820

Countries citing papers authored by Hammer Sm

Since Specialization
Citations

This map shows the geographic impact of Hammer Sm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hammer Sm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hammer Sm more than expected).

Fields of papers citing papers by Hammer Sm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hammer Sm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hammer Sm. The network helps show where Hammer Sm may publish in the future.

Co-authorship network of co-authors of Hammer Sm

This figure shows the co-authorship network connecting the top 25 collaborators of Hammer Sm. A scholar is included among the top collaborators of Hammer Sm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hammer Sm. Hammer Sm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sm, Hammer, et al.. (2025). In vitro model of bacterial biofilm mineralization in complex humid environments: a proof of concept study. Frontiers in Bioengineering and Biotechnology. 12. 1496117–1496117.
2.
Kerr, Stephen J., Jintanat Ananworanich, Hammer Sm, et al.. (2011). Cardiovascular risk assessment in persons with HIV infection in the developing world: comparing three risk equations in a cohort of HIV-infected Thais. HIV Medicine. 12(8). 510–515. 32 indexed citations
3.
Kerr, Stephen J., Jintanat Ananworanich, Hammer Sm, et al.. (2010). Cardiovascular risk assessment in persons with HIV in the developing world: comparing three risk equations in a cohort of HIV‐infected Thais. Journal of the International AIDS Society. 13(S4). 2 indexed citations
4.
Sm, Hammer & Louise Pedneault. (2000). Antiretroviral resistance testing comes of age.. PubMed. 5(1). 23–6. 17 indexed citations
5.
Gilbert, Peter B., Victor DeGruttola, & Hammer Sm. (1998). Efficient Trial Designs for Studying Combination Antiretroviral Treatments in Patients with Various Resistance Profiles. The Journal of Infectious Diseases. 178(2). 340–348. 4 indexed citations
6.
Arens, Max Q., William A. Meyer, Donald Brambilla, et al.. (1997). Stabilities of free and complexed human immunodeficiency virus p24 antigens during short- and long-term storage. Journal of Clinical Microbiology. 35(9). 2413–2416. 1 indexed citations
7.
Kahn, Jeffrey P., Hammer Sm, David Katzenstein, et al.. (1997). Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals.. PubMed. 2(4). 237–47. 2 indexed citations
8.
Lund-Hanssen, Håkon, et al.. (1996). Isokinetic muscle performance in healthy female handball players and players with a unilateral anterior cruciate ligament reconstruction. Scandinavian Journal of Medicine and Science in Sports. 6(3). 172–175. 35 indexed citations
9.
Holm, Inger, Hammer Sm, S. Larsen, Lars Nordsletten, & Harald Steen. (1995). Can a regular leg extension bench be used in testing deficits of the quadriceps muscle during rehabilitation?. Scandinavian Journal of Medicine and Science in Sports. 5(1). 29–35. 15 indexed citations
10.
Holen, Ketil Jarl, et al.. (1995). Surgical treatment of medial tibial stress syndrome (shin splint) by fasciotomy of the superficial posterior compartment of the leg. Scandinavian Journal of Medicine and Science in Sports. 5(1). 40–43. 23 indexed citations
11.
Japour, Anthony J., Jean Marie Arduino, Hammer Sm, et al.. (1994). Dideoxynucleoside resistance emerges with prolonged zidovudine monotherapy. The RV43 Study Group. Antimicrobial Agents and Chemotherapy. 38(2). 307–314. 53 indexed citations
12.
Sm, Hammer, et al.. (1994). Issues in combination antiretroviral therapy: a review.. PubMed. 7 Suppl 2. S24–35; discussion S35. 17 indexed citations
13.
Yéni, P., Robert T. Schooley, & Hammer Sm. (1993). Antiretroviral and immune-based therapies: update.. PubMed. 7 Suppl 1. S173–84. 2 indexed citations
14.
Sm, Hammer, et al.. (1992). Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition. Antimicrobial Agents and Chemotherapy. 36(3). 509–520. 28 indexed citations
15.
Kim, Sung Woo, et al.. (1991). Effect of the Calcium Channel Blocker Verapamil on Human Immunodeficiency Virus Type 1 Replication in Lymphoid Cells. The Journal of Infectious Diseases. 164(1). 53–60. 7 indexed citations
16.
Gillis, Jean‐Marie, et al.. (1990). Effects of Recombinant Soluble CD4 (rCD4) on HIV-1 Infection of Monocyte/Macrophages. The Journal of Infectious Diseases. 161(1). 1–6. 25 indexed citations
18.
Sm, Hammer, et al.. (1989). Inactivation of human immunodeficiency virus by Betadine products and chlorhexidine.. PubMed. 2(1). 16–20. 55 indexed citations
19.
Shaffer, David R., Richard H. Pearl, Rachel Jenkins, et al.. (1987). HTLV-III/LAV infection in kidney and liver transplantation.. PubMed. 19(1 Pt 3). 2176–8. 20 indexed citations
20.
Sm, Hammer, et al.. (1986). Effects of recombinant interleukin-2 on resting human T lymphocytes.. PubMed. 5(1). 36–44. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026